Global Severe Eosinophilic Asthma Treatment Market Growth (Status and Outlook) 2024-2030

August 2024 | 76 pages | ID: G04598C2FE43EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Severe Eosinophilic Asthma Treatment market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Severe Eosinophilic Asthma Treatment Industry Forecast” looks at past sales and reviews total world Severe Eosinophilic Asthma Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Severe Eosinophilic Asthma Treatment sales for 2023 through 2029. With Severe Eosinophilic Asthma Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Severe Eosinophilic Asthma Treatment industry.

This Insight Report provides a comprehensive analysis of the global Severe Eosinophilic Asthma Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Severe Eosinophilic Asthma Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Severe Eosinophilic Asthma Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Severe Eosinophilic Asthma Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Severe Eosinophilic Asthma Treatment.

United States market for Severe Eosinophilic Asthma Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Severe Eosinophilic Asthma Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Severe Eosinophilic Asthma Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Severe Eosinophilic Asthma Treatment players cover AstraZeneca, GSK, Genentech (Roche Group) & Novartis, Regeneron Pharmaceuticals & Sanofi, Teva Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Severe Eosinophilic Asthma Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Intravenous Infusion
• Subcutaneous Injection

Segmentation by Application:

• Children
• Adults
• Teenagers

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Segmentation by Type:

• Intravenous Infusion
• Subcutaneous Injection

Segmentation by Application:

• Children
• Adults
• Teenagers

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• GSK
• Genentech (Roche Group) & Novartis
• Regeneron Pharmaceuticals & Sanofi
• Teva Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Severe Eosinophilic Asthma Treatment Market Size 2019-2030
  2.1.2 Severe Eosinophilic Asthma Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030)
  2.1.3 World Current & Future Analysis for Severe Eosinophilic Asthma Treatment by Country/Region, 2019, 2023 & 2030
2.2 Severe Eosinophilic Asthma Treatment Segment by Type
  2.2.1 Intravenous Infusion
  2.2.2 Subcutaneous Injection
2.3 Severe Eosinophilic Asthma Treatment Market Size by Type
  2.3.1 Severe Eosinophilic Asthma Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Type (2019-2024)
2.4 Severe Eosinophilic Asthma Treatment Segment by Application
  2.4.1 Children
  2.4.2 Adults
  2.4.3 Teenagers
2.5 Severe Eosinophilic Asthma Treatment Market Size by Application
  2.5.1 Severe Eosinophilic Asthma Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Application (2019-2024)

3 SEVERE EOSINOPHILIC ASTHMA TREATMENT MARKET SIZE BY PLAYER

3.1 Severe Eosinophilic Asthma Treatment Market Size Market Share by Player
  3.1.1 Global Severe Eosinophilic Asthma Treatment Revenue by Player (2019-2024)
  3.1.2 Global Severe Eosinophilic Asthma Treatment Revenue Market Share by Player (2019-2024)
3.2 Global Severe Eosinophilic Asthma Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SEVERE EOSINOPHILIC ASTHMA TREATMENT BY REGION

4.1 Severe Eosinophilic Asthma Treatment Market Size by Region (2019-2024)
4.2 Global Severe Eosinophilic Asthma Treatment Annual Revenue by Country/Region (2019-2024)
4.3 Americas Severe Eosinophilic Asthma Treatment Market Size Growth (2019-2024)
4.4 APAC Severe Eosinophilic Asthma Treatment Market Size Growth (2019-2024)
4.5 Europe Severe Eosinophilic Asthma Treatment Market Size Growth (2019-2024)
4.6 Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Severe Eosinophilic Asthma Treatment Market Size by Country (2019-2024)
5.2 Americas Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024)
5.3 Americas Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Severe Eosinophilic Asthma Treatment Market Size by Region (2019-2024)
6.2 APAC Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024)
6.3 APAC Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Severe Eosinophilic Asthma Treatment Market Size by Country (2019-2024)
7.2 Europe Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024)
7.3 Europe Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Severe Eosinophilic Asthma Treatment by Region (2019-2024)
8.2 Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SEVERE EOSINOPHILIC ASTHMA TREATMENT MARKET FORECAST

10.1 Global Severe Eosinophilic Asthma Treatment Forecast by Region (2025-2030)
  10.1.1 Global Severe Eosinophilic Asthma Treatment Forecast by Region (2025-2030)
  10.1.2 Americas Severe Eosinophilic Asthma Treatment Forecast
  10.1.3 APAC Severe Eosinophilic Asthma Treatment Forecast
  10.1.4 Europe Severe Eosinophilic Asthma Treatment Forecast
  10.1.5 Middle East & Africa Severe Eosinophilic Asthma Treatment Forecast
10.2 Americas Severe Eosinophilic Asthma Treatment Forecast by Country (2025-2030)
  10.2.1 United States Market Severe Eosinophilic Asthma Treatment Forecast
  10.2.2 Canada Market Severe Eosinophilic Asthma Treatment Forecast
  10.2.3 Mexico Market Severe Eosinophilic Asthma Treatment Forecast
  10.2.4 Brazil Market Severe Eosinophilic Asthma Treatment Forecast
10.3 APAC Severe Eosinophilic Asthma Treatment Forecast by Region (2025-2030)
  10.3.1 China Severe Eosinophilic Asthma Treatment Market Forecast
  10.3.2 Japan Market Severe Eosinophilic Asthma Treatment Forecast
  10.3.3 Korea Market Severe Eosinophilic Asthma Treatment Forecast
  10.3.4 Southeast Asia Market Severe Eosinophilic Asthma Treatment Forecast
  10.3.5 India Market Severe Eosinophilic Asthma Treatment Forecast
  10.3.6 Australia Market Severe Eosinophilic Asthma Treatment Forecast
10.4 Europe Severe Eosinophilic Asthma Treatment Forecast by Country (2025-2030)
  10.4.1 Germany Market Severe Eosinophilic Asthma Treatment Forecast
  10.4.2 France Market Severe Eosinophilic Asthma Treatment Forecast
  10.4.3 UK Market Severe Eosinophilic Asthma Treatment Forecast
  10.4.4 Italy Market Severe Eosinophilic Asthma Treatment Forecast
  10.4.5 Russia Market Severe Eosinophilic Asthma Treatment Forecast
10.5 Middle East & Africa Severe Eosinophilic Asthma Treatment Forecast by Region (2025-2030)
  10.5.1 Egypt Market Severe Eosinophilic Asthma Treatment Forecast
  10.5.2 South Africa Market Severe Eosinophilic Asthma Treatment Forecast
  10.5.3 Israel Market Severe Eosinophilic Asthma Treatment Forecast
  10.5.4 Turkey Market Severe Eosinophilic Asthma Treatment Forecast
10.6 Global Severe Eosinophilic Asthma Treatment Forecast by Type (2025-2030)
10.7 Global Severe Eosinophilic Asthma Treatment Forecast by Application (2025-2030)
  10.7.1 GCC Countries Market Severe Eosinophilic Asthma Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Severe Eosinophilic Asthma Treatment Product Offered
  11.1.3 AstraZeneca Severe Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 GSK
  11.2.1 GSK Company Information
  11.2.2 GSK Severe Eosinophilic Asthma Treatment Product Offered
  11.2.3 GSK Severe Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 GSK Main Business Overview
  11.2.5 GSK Latest Developments
11.3 Genentech (Roche Group) & Novartis
  11.3.1 Genentech (Roche Group) & Novartis Company Information
  11.3.2 Genentech (Roche Group) & Novartis Severe Eosinophilic Asthma Treatment Product Offered
  11.3.3 Genentech (Roche Group) & Novartis Severe Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Genentech (Roche Group) & Novartis Main Business Overview
  11.3.5 Genentech (Roche Group) & Novartis Latest Developments
11.4 Regeneron Pharmaceuticals & Sanofi
  11.4.1 Regeneron Pharmaceuticals & Sanofi Company Information
  11.4.2 Regeneron Pharmaceuticals & Sanofi Severe Eosinophilic Asthma Treatment Product Offered
  11.4.3 Regeneron Pharmaceuticals & Sanofi Severe Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Regeneron Pharmaceuticals & Sanofi Main Business Overview
  11.4.5 Regeneron Pharmaceuticals & Sanofi Latest Developments
11.5 Teva Pharmaceuticals
  11.5.1 Teva Pharmaceuticals Company Information
  11.5.2 Teva Pharmaceuticals Severe Eosinophilic Asthma Treatment Product Offered
  11.5.3 Teva Pharmaceuticals Severe Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Teva Pharmaceuticals Main Business Overview
  11.5.5 Teva Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Severe Eosinophilic Asthma Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Severe Eosinophilic Asthma Treatment Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intravenous Infusion
Table 4. Major Players of Subcutaneous Injection
Table 5. Severe Eosinophilic Asthma Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Type (2019-2024)
Table 8. Severe Eosinophilic Asthma Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Application (2019-2024)
Table 11. Global Severe Eosinophilic Asthma Treatment Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Severe Eosinophilic Asthma Treatment Revenue Market Share by Player (2019-2024)
Table 13. Severe Eosinophilic Asthma Treatment Key Players Head office and Products Offered
Table 14. Severe Eosinophilic Asthma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Severe Eosinophilic Asthma Treatment Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Region (2019-2024)
Table 19. Global Severe Eosinophilic Asthma Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Severe Eosinophilic Asthma Treatment Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Severe Eosinophilic Asthma Treatment Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Severe Eosinophilic Asthma Treatment Market Size Market Share by Country (2019-2024)
Table 23. Americas Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Severe Eosinophilic Asthma Treatment Market Size Market Share by Type (2019-2024)
Table 25. Americas Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Severe Eosinophilic Asthma Treatment Market Size Market Share by Application (2019-2024)
Table 27. APAC Severe Eosinophilic Asthma Treatment Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Severe Eosinophilic Asthma Treatment Market Size Market Share by Region (2019-2024)
Table 29. APAC Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Severe Eosinophilic Asthma Treatment Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Severe Eosinophilic Asthma Treatment Market Size Market Share by Country (2019-2024)
Table 33. Europe Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Severe Eosinophilic Asthma Treatment
Table 39. Key Market Challenges & Risks of Severe Eosinophilic Asthma Treatment
Table 40. Key Industry Trends of Severe Eosinophilic Asthma Treatment
Table 41. Global Severe Eosinophilic Asthma Treatment Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Severe Eosinophilic Asthma Treatment Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Severe Eosinophilic Asthma Treatment Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Severe Eosinophilic Asthma Treatment Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. AstraZeneca Details, Company Type, Severe Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 46. AstraZeneca Severe Eosinophilic Asthma Treatment Product Offered
Table 47. AstraZeneca Severe Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. AstraZeneca Main Business
Table 49. AstraZeneca Latest Developments
Table 50. GSK Details, Company Type, Severe Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 51. GSK Severe Eosinophilic Asthma Treatment Product Offered
Table 52. GSK Severe Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. GSK Main Business
Table 54. GSK Latest Developments
Table 55. Genentech (Roche Group) & Novartis Details, Company Type, Severe Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 56. Genentech (Roche Group) & Novartis Severe Eosinophilic Asthma Treatment Product Offered
Table 57. Genentech (Roche Group) & Novartis Severe Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Genentech (Roche Group) & Novartis Main Business
Table 59. Genentech (Roche Group) & Novartis Latest Developments
Table 60. Regeneron Pharmaceuticals & Sanofi Details, Company Type, Severe Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 61. Regeneron Pharmaceuticals & Sanofi Severe Eosinophilic Asthma Treatment Product Offered
Table 62. Regeneron Pharmaceuticals & Sanofi Severe Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Regeneron Pharmaceuticals & Sanofi Main Business
Table 64. Regeneron Pharmaceuticals & Sanofi Latest Developments
Table 65. Teva Pharmaceuticals Details, Company Type, Severe Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 66. Teva Pharmaceuticals Severe Eosinophilic Asthma Treatment Product Offered
Table 67. Teva Pharmaceuticals Severe Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Teva Pharmaceuticals Main Business
Table 69. Teva Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Severe Eosinophilic Asthma Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Severe Eosinophilic Asthma Treatment Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Severe Eosinophilic Asthma Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Severe Eosinophilic Asthma Treatment Sales Market Share by Country/Region (2023)
Figure 8. Severe Eosinophilic Asthma Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Type in 2023
Figure 10. Severe Eosinophilic Asthma Treatment in Children
Figure 11. Global Severe Eosinophilic Asthma Treatment Market: Children (2019-2024) & ($ millions)
Figure 12. Severe Eosinophilic Asthma Treatment in Adults
Figure 13. Global Severe Eosinophilic Asthma Treatment Market: Adults (2019-2024) & ($ millions)
Figure 14. Severe Eosinophilic Asthma Treatment in Teenagers
Figure 15. Global Severe Eosinophilic Asthma Treatment Market: Teenagers (2019-2024) & ($ millions)
Figure 16. Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Application in 2023
Figure 17. Global Severe Eosinophilic Asthma Treatment Revenue Market Share by Player in 2023
Figure 18. Global Severe Eosinophilic Asthma Treatment Market Size Market Share by Region (2019-2024)
Figure 19. Americas Severe Eosinophilic Asthma Treatment Market Size 2019-2024 ($ millions)
Figure 20. APAC Severe Eosinophilic Asthma Treatment Market Size 2019-2024 ($ millions)
Figure 21. Europe Severe Eosinophilic Asthma Treatment Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size 2019-2024 ($ millions)
Figure 23. Americas Severe Eosinophilic Asthma Treatment Value Market Share by Country in 2023
Figure 24. United States Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Severe Eosinophilic Asthma Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Severe Eosinophilic Asthma Treatment Market Size Market Share by Type (2019-2024)
Figure 30. APAC Severe Eosinophilic Asthma Treatment Market Size Market Share by Application (2019-2024)
Figure 31. China Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 35. India Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Severe Eosinophilic Asthma Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Severe Eosinophilic Asthma Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Severe Eosinophilic Asthma Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 41. France Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Severe Eosinophilic Asthma Treatment Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 54. APAC Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 55. Europe Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 57. United States Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 58. Canada Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 59. Mexico Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 60. Brazil Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 61. China Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 62. Japan Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 63. Korea Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 65. India Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 66. Australia Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 67. Germany Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 68. France Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 69. UK Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 70. Italy Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 71. Russia Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 72. Egypt Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 73. South Africa Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 74. Israel Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 75. Turkey Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Severe Eosinophilic Asthma Treatment Market Size 2025-2030 ($ millions)
Figure 77. Global Severe Eosinophilic Asthma Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Severe Eosinophilic Asthma Treatment Market Size Market Share Forecast by Application (2025-2030)